Figure 2From: Inhibitory effects of aromatase inhibitor on estrogen receptor-alpha positive ovarian cancer in miceComparison of the survival period in the letrozole group and the control group. (A) Appearances, intraperitoneal finding and bloody ascites of peritoneal carcinomatosa mice model derived from OVCAR-3 cells. Asterisks show disseminated foci of the cancer. (B) The survival period in the letrozole group was extended significantly beyond that in the control group in ERα positive OVCAR-3 tumors (P < 0.05). (C) There was no signicant difference in survival period between the groups in ERα negative DISS tumors.Back to article page